Compare PROF & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROF | ELLO |
|---|---|---|
| Founded | N/A | 1987 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.8M | 255.4M |
| IPO Year | 2017 | 1998 |
| Metric | PROF | ELLO |
|---|---|---|
| Price | $5.75 | $21.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 121.3K | 1.8K |
| Earning Date | 05-07-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,098,000.00 | N/A |
| Revenue This Year | $92.40 | N/A |
| Revenue Next Year | $64.10 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 50.73 | N/A |
| 52 Week Low | $4.91 | $17.00 |
| 52 Week High | $8.95 | $30.34 |
| Indicator | PROF | ELLO |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 55.62 |
| Support Level | $5.78 | $21.72 |
| Resistance Level | $6.23 | $23.13 |
| Average True Range (ATR) | 0.36 | 0.74 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 22.31 | 54.15 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions. Geographically, the company operates in segments: Italy; Spain; USA; Netherland and Israel. It derives maximum revenue from Spain.